Bundamedik Tbk vs Morenzo Abadi Perkasa Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Morenzo Abadi Perkasa Tbk. trades at Rp69 (market cap 147.05B, 8.6M 24h volume). The key difference: Bundamedik Tbk is far larger — about 10.3× Morenzo Abadi Perkasa Tbk.'s market cap, and Morenzo Abadi Perkasa Tbk. is more actively traded (8.6M versus 536.7K). Which is the better fit depends on your goals.
| BMHS | ENZO | |
|---|---|---|
Market Cap | 1.51T | 147.05B |
Volume | 536.7K | 8.6M |
Lot | 5.37K | 85.96K |
Turnover | 93.41M | 591.25M |
Average Price | 174.05 | 68.78 |
Value | 93.41M | 591.25M |
Indicative Equilibrium Price | 176 | 69 |
Indicative Equilibrium Volume | 100 | 4.14K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Read more on ENZO →